Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of Escherichia coli and Pseudomonas aeruginosa

The rise in antimicrobial resistant bacteria is limiting the number of effective treatments for bacterial infections. Escherichia coli and Pseudomonas aeruginosa are two of the pathogens with the highest prevalence of resistance, and with the greatest need for new antimicrobial agents. Combinations...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridyard, Kylen E., Elsawy, Mariam, Mattrasingh, Destina, Klein, Darien, Strehmel, Janine, Beaulieu, Carole, Wong, Alex, Overhage, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952724/
https://www.ncbi.nlm.nih.gov/pubmed/36830299
http://dx.doi.org/10.3390/antibiotics12020389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952724/
https://www.ncbi.nlm.nih.gov/pubmed/36830299
http://dx.doi.org/10.3390/antibiotics12020389

Ejemplares similares